BEAM Beam Therapeutics Inc.: institutional ownership and insider trading
295 funds reported holding $4.47B of Beam Therapeutics Inc. in their latest 13F filings; in Q2 2026 funds net bought $34.3M, with 55 new positions and 32 funds selling out; over the last 12 months insiders bought $0 and sold $19.7M on the open market.
Famous investors holding BEAM
- Cathie Wood (ARK Investment Management): $351M, 2.3% of the portfolio
- Stanley Druckenmiller (Duquesne Family Office): $5.27M, 0.1% of the portfolio
- Two Sigma (Two Sigma Investments): $47.6M, 0.0% of the portfolio
- Renaissance Technologies (Renaissance Technologies): $15.3M, 0.0% of the portfolio
- Ken Griffin (Citadel Advisors): $10.8M, 0.0% of the portfolio
- D. E. Shaw (D. E. Shaw & Co.): $4.48M, 0.0% of the portfolio
- Izzy Englander (Millennium Management): $2.89M, 0.0% of the portfolio
Largest institutional holders of BEAM
- FMR LLC — $433M
- FARALLON CAPITAL MANAGEMENT, L.L.C. — $351M
- ARK Investment Management LLC — $351M
- Banque Cantonale Vaudoise — $343M
- BlackRock, Inc. (BLK) — $309M
- VANGUARD GROUP INC — $255M
- STATE STREET CORP (STT, STT-PG) — $200M
- VANGUARD PORTFOLIO MANAGEMENT LLC — $169M
- VANGUARD CAPITAL MANAGEMENT LLC — $158M
- ARCH Venture Management, LLC — $156M
Recent BEAM insider trades
- Oct 16, 2026: Evans John M. sold 50,000 shares ($1.19M)
- Oct 1, 2026: Cavanagh Bethany J sold 187 shares ($4.57K)
- Jul 27, 2026: Simon Amy sold 16,667 shares ($429K)
- Jun 30, 2026: Simon Amy sold 373 shares ($13.0K)
5%+ owners
- Farallon Capital Management, L.L.C.: 10.0% (Schedule 13G/A, filed Aug 13, 2026)
- ARK Investment Management LLC: 10.0% (Schedule 13G/A, filed Aug 14, 2026)
- Vanguard Capital Management: 5.0% (Schedule 13G, filed Apr 29, 2026)